RxDoctor Payments DataLook up a doctor →

Brian Knighton, DO

Family Medicine · Freeport, MENPI 1700824000

Payments from drug & device makers

$28,999in general payments, 2019–2025

Across 1,585 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Novo Nordisk$3K
  • AstraZeneca$3K
  • Pfizer$3K
  • Amgen$2K
  • Boehringer Ingelheim$2K
  • plus $13K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)324$4,522
Novo Nordisk166$2,939
AstraZeneca121$2,820
Pfizer197$2,719
Amgen81$1,794
Boehringer Ingelheim71$1,592
GSK92$1,515
Lilly USA, LLC66$1,242
Axsome Therapeutics, Inc.36$976
Merck47$922
Takeda Pharmaceuticals U.S.A., Inc.50$860
Bayer26$688
Daiichi Sankyo Inc.27$512
Lundbeck LLC18$508
Exact Sciences17$418
Corcept Therapeutics18$337
Phathom Pharmaceuticals, Inc.16$319
Amarin Pharma, Inc.17$279
Johnson & Johnson13$268
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$262
Sunovion Pharmaceuticals Inc.10$246
Eisai Inc.16$244
Teva Pharmaceuticals USA, Inc.10$243
Biohaven Pharmaceutical Holding Company Ltd.18$231
Dexcom, Inc.8$226
Abbott10$194
Novartis10$184
Madrigal Pharmaceuticals9$182
E.r. Squibb & Sons, L.L.C.8$161
Nestle Healthcare Nutrition Inc.8$142
Regeneron Healthcare Solutions, Inc.1$125
Sanofi-aventis U.S. LLC6$107
Otsuka America Pharmaceutical, Inc.4$95
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$88
Mayne Pharma Commercial LLC1$84
Sumitomo Pharma America, Inc.4$79
Astellas Pharma US Inc3$76
Sanofi Pasteur Inc.3$65
Esperion Therapeutics, Inc.3$65
Biohaven Pharmaceuticals, Inc.3$62
Corium, LLC3$61
Radius Health, Inc.3$55
Verona Pharma, Inc.2$52
Collegium Pharmaceutical, Inc.2$45
Myovant Sciences Inc.2$44
Mylan Specialty L.p.3$42
Idorsia Pharmaceuticals US Inc2$40
Kiniksa Pharmaceuticals International, PLC1$34
Gilead1$28
Biocryst US Sales Co., LLC1$26
Inspire Medical Systems, Inc.1$25
Shire North American Group Inc1$22
Baxter Healthcare1$22
Impel Pharmaceuticals Inc.1$18
AMAG Pharmaceuticals, Inc.1$18
Organogenesis Inc.1$17
Adlon Therapeutics L.p.1$16
Circassia Inc.1$16
Azurity Pharmaceuticals, Inc.1$14
Organon2$12

How this compares

$28,999 in reported general payments places this provider in the 95th percentile of 466 family medicine providers in Maine.

See all family medicine providers in Maine

Medicare billing

Part B allowed, 2024
$33,040
Medicare patients
95
Services billed
600

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Freeport

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →